Home Cart 0 Sign in  

[ CAS No. 290832-43-8 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 290832-43-8
Chemical Structure| 290832-43-8
Structure of 290832-43-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 290832-43-8 ]

Related Doc. of [ 290832-43-8 ]

Alternatived Products of [ 290832-43-8 ]

Product Details of [ 290832-43-8 ]

CAS No. :290832-43-8 MDL No. :MFCD08059517
Formula : C8H8BF3O4 Boiling Point : -
Linear Structure Formula :- InChI Key :PZDNMFGRXYPDJA-UHFFFAOYSA-N
M.W :235.95 Pubchem ID :22249160
Synonyms :

Calculated chemistry of [ 290832-43-8 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 4
Num. H-bond acceptors : 7.0
Num. H-bond donors : 2.0
Molar Refractivity : 49.44
TPSA : 58.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.98
Log Po/w (WLOGP) : 1.53
Log Po/w (MLOGP) : 0.22
Log Po/w (SILICOS-IT) : -0.09
Consensus Log Po/w : 0.73

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.56
Solubility : 0.644 mg/ml ; 0.00273 mol/l
Class : Soluble
Log S (Ali) : -2.84
Solubility : 0.339 mg/ml ; 0.00143 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.05
Solubility : 2.1 mg/ml ; 0.00891 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.39

Safety of [ 290832-43-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 290832-43-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 290832-43-8 ]

[ 290832-43-8 ] Synthesis Path-Downstream   1~14

  • 1
  • [ 290832-43-8 ]
  • [ 200956-08-7 ]
  • [ 200952-78-9 ]
  • 2
  • (5-bromo-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl] amine [ No CAS ]
  • [ 290832-43-8 ]
  • [ 1100873-14-0 ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; at 80℃; for 16h; B. In a pressure tube, a mixture of the product from step A (1 equivalent), 2- methoxy-5-trifluoromethoxyphenylboronic acid (1.6 equivalents) and Pd [(PPH3)] 4 (0.04 equivalents) in toluene (4 ml/mmol of product from step A), ethanol (. 2 ml/mmol of product from step A) and aqueous [K2CO3] (2M, 2 [ML/MMOL] of product from step A) is heated to [80C] for 16 hours. The mixture is diluted with ethyl acetate, and the organic fraction washed with NaOH (2M, 20 mL/mmol of product from step A) and brine (3 x 20 ml/mmol of product from step A), then dried [(MGS04),] filtered and the solvent removed under reduced pressure. Chromatography of the residue provides [(3- (2-METHOXY-5-TRIFLUOROMETHOXYPHENYL)-6-] chloropyrazin-2-yl) [ (4-methoxyphenyl) methyl] amine.
  • 3
  • [ 710-18-9 ]
  • [ 290832-43-8 ]
YieldReaction ConditionsOperation in experiment
38% To a cooled (-300C) solution of <strong>[710-18-9]1-methoxy-4-(trifluoromethoxy)benzene</strong> (960mg, 5mmol) in THF (1OmL) was added n-BuLi (2.5M in hexane) (2.2OmL, 5.50mmol) over 10 min. The reaction mixture was stirred for 30 min, cooled to -78 0C and triisopropylborane (1.3Og, 7.0mmol) was added over 5 min. The reaction mixture was stirred for 1 h at -78 C and 1 M hydrochloric acid solution (6mL) was added. After warming to rt, the mixture was stirred vigorously for 30 min. The phases were separated and the aqueous phase was extracted with EtOAc. The organic phase was washed with water, brine, dried over magnesium sulfate and the solvent was removed in vacuo to give the crude residue. Trituration with hexane afforded the desired product as a white solid, 450mg (38%). LRMS (APCI) 235 [MH"]
  • 4
  • [ 290832-43-8 ]
  • [ 895572-36-8 ]
YieldReaction ConditionsOperation in experiment
70% To a solution of the compound of preparation 21 (450mg, 1.90mmol) in water (3mL) was added sodium hydroxide (114mg, 2.85mmol), sodium hydrogen carbonate (1.6Og, 19.0mmol), acetone (4mL) and EDTA (58mg, 0.2mmol) at rt. The mixture was cooled to 0 0C and Oxone (1.3Og, 2.10mmol) was added portionwise over 5 min. The mixture was warmed to rt and stirred for 2h. 2M hydrochloric acid solution (15mL) was added and the phases were separated. The aqueous phase was extracted with EtOAc, the organic extract was dried over magnesium sulfate and the solvent was removed in vacuo to afford the desired product as a yellow oil, 277mg (70%). EPO <DP n="29"/>LRMS (APCI) 207 [MH"]
  • 5
  • (5-bromo-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl] amine [ No CAS ]
  • [ 584-08-7 ]
  • [ 290832-43-8 ]
  • [ 1100873-13-9 ]
YieldReaction ConditionsOperation in experiment
Pd(PPh3)4; In ethanol; toluene; B. In a pressure tube, a mixture of the product from step A (1 equivalent), 2-methoxy-5-trifluoromethoxyphenylboronic acid (1.6 equivalents) and Pd(PPh3)4 (0.04 equivalents) in toluene (4 ml/mmol of product from step A), ethanol (0.2 ml/ mmol of product from step A) and aqueous K2CO3 (2M, 2 ml/mmol of product from step A) is heated to 80 C. for 16 h. The mixture was diluted with ethyl acetate, and the organic fraction washed with NaOH (2M, 20 mL/mmol of product from step A) and brine (3*20 ml/mmol of product from step A), then dried (MgSO4), filtered and the solvent removed under reduced pressure. Chromatography of the residue provided (3-(2-methoxy-5-trifluoromethoxyphenyl)-6-chloropyrazin-2-yl)[(4-methoxyphenyl)methyl]amine.
  • 6
  • [ 290832-43-8 ]
  • [ 1354819-26-3 ]
YieldReaction ConditionsOperation in experiment
A suspension of 2-methoxy-5-(trifluoromethoxy)phenylboronic acid (23.0 g, 97.5 mmol) in dichloromethane (140 ml_) was cooled to 0 C and boron tribromide (9.4 ml_,10 mmol) was added drop-wise over 30 min. After stirring for 3 hours, additional boron tribromide (2 ml_) was added. The reaction mixture was poured into ice water and stirred for 20 min. The dichloromethane was removed in vacuo and the white solid collected by filtration and washed with water before drying in vacuo to afford the title compound(20.8 g). HNMR (d4-Methanol): δ 6.78 (d, 1 H), 7.1 1 (d, 1 H), 7.40 (br s, 1 H).LCMS Rt = 1 .67 min MS m/z 221 [M-H]-
  • 7
  • [ 290832-43-8 ]
  • [ 1354819-27-4 ]
  • 8
  • [ 290832-43-8 ]
  • [ 1354819-28-5 ]
  • 9
  • [ 290832-43-8 ]
  • 4-[2-(3-amino-1H-pyrazol-4-yl)-4-(trifluoromethoxy)phenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide dihydrochloride [ No CAS ]
  • 10
  • C21H21BrIN3O3 [ No CAS ]
  • [ 139301-27-2 ]
  • [ 290832-43-8 ]
  • C34H27F6N3O6 [ No CAS ]
  • 11
  • 3-bromo-5-(methylsulfonyl)-4H-1,2,4-triazole [ No CAS ]
  • [ 290832-43-8 ]
  • C11H10F3N3O4S [ No CAS ]
  • 12
  • [ 121-43-7 ]
  • 2-bromo-1-methoxy-4-(trifluoromethoxy)benzene [ No CAS ]
  • [ 290832-43-8 ]
YieldReaction ConditionsOperation in experiment
28% n-Butyllithium (1.6M in hexanes, 3.8 mL, 6 mmol) was added dropwise to a cooled (-78[deg.] C.) solution of 2-bromo-1-methoxy-4-(trifluoromethoxy)benzene (Description 16, 1.5 g, 5.5 mmol) in tetrahydrofuran (prefiltered through alumina, 18 mL) internal temperature H NMR (360 MHz, CDCl3) [delta]3.93 (3H, s), 5.84 (2H, s), 6.90 (1H, d, J 9.0 Hz), 7.29 (1H, m) and 7.70 (1H, J 2.6 Hz).
  • 13
  • [ 200956-13-4 ]
  • [ 290832-43-8 ]
  • 14
  • [ 828-27-3 ]
  • [ 290832-43-8 ]
Same Skeleton Products
Historical Records